PCA
HIMS icon

Providence Capital Advisors’s Hims & Hers Health HIMS Stock Holding History

Providence Capital Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31
Closed -$577 – 204
2024
Q3 		$577 Hold
31
– – ﹤0.01% 335
2024
Q2 		$633 Buy
+31
New +$516 ﹤0.01% 334

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Providence Capital Advisors's HIMS Position: Q4 2024 in Review

Providence Capital Advisors sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 31 shares — an estimated $577 sold.

Providence Capital Advisors first reported a position in HIMS in Q2 2024 and held it in 2 quarters. The position peaked at $633 in Q2 2024. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

  • Providence Capital Advisors reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
  • Providence Capital Advisors sold 31 Hims & Hers Health shares in Q4 2024, an estimated $577.
  • Providence Capital Advisors first reported a position in Hims & Hers Health in Q2 2024 and held it in 2 quarters.
  • Providence Capital Advisors's Hims & Hers Health position peaked at $633 in Q2 2024.
  • 394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Providence Capital Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.